FrancophonIA/ELRC3.0 huggingface dataset:
English: In a variety of preclinical safety studies conducted in several animal species with amlodipine, valsartan, hydrochlorothiazide, valsartan/hydrochlorothiazide, amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide (Exforge HCT), there was no evidence of systemic or target organ toxicity that would adversely affect the development of Exforge HCT for clinical use in humans.
Croatian: U nizu nekliničkih ispitivanja sigurnosti, provedenih na nekoliko vrsta životinja s amlodipinom, valsartanom, hidroklorotiazidom, valsartanom/hidroklorotiazidom, amlodipinom/valsartanom te amlodipinom/valsartanom/hidroklorotiazidom (Exforge HCT), nije bilo dokaza sistemske toksičnosti ili toksičnosti za pojedini ciljni organ koji bi negativno utjecali na razvoj Exforge HCT-a za kliničku primjenu u ljudi.
English: Exforge HCT combines three antihypertensive compounds with complementary mechanisms to control blood pressure in patients with essential hypertension: amlodipine belongs to the calcium antagonist class and valsartan to the angiotensin II antagonist class of medicines and hydrochlorothiazide belongs to the thiazide diuretics class of medicines.
Croatian: Exforge HCT kombinira tri antihipertenzivna sastojka s komplementarnim mehanizmima kontrole krvnog tlaka u bolesnika s esencijalnom hipertenzijom: amlodipin pripada skupini kalcijevih antagonista, valsartan pripada skupini antagonista angiotenzina II, a hidroklorotiazid pripada skupini tiazidnih diuretika.
English: The amlodipine component of Exforge HCT inhibits the transmembrane entry of calcium ions into cardiac and vascular smooth muscle.
Croatian: Amlodipinska komponenta Exforge HCT-a inhibira transmembranski ulaz iona kalcija u srčani mišić i glatki mišić krvnih žila.
English: What Exforge HCT contains
Croatian: Što Exforge HCT sadrži
English: If you get these symptoms, stop taking Exforge HCT and contact your doctor straight away.
Croatian: Ako dobijete ove simptome, prekinite uzimati Exforge HCT i odmah se javite svom liječniku.
English: Since renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity may presumably be increased further with Exforge HCT.
Croatian: Budući da je bubrežni klirens litija smanjen s tiazidima, rizik od toksičnosti litija vjerojatno se može povećati s Exforge HCT-om.
English: In the controlled trial of Exforge HCT, the counteracting effects of valsartan 320 mg and hydrochlorothiazide 25 mg on serum potassium approximately balanced each other in many patients.
Croatian: U kontroliranom ispitivanju Exforge HCT-a, suprotni učinci 320 mg valsartana i 25 mg hidroklorotiazida na kalij u serumu su se približno uravnotežili u mnogih bolesnika.
English: In case severe or rapid hyponatraemia develops during Exforge HCT therapy, the treatment should be discontinued until normalisation of natraemia.
Croatian: U slučaju razvoja teškog ili brzog oblika hiponatrijemije tijekom terapije Exforge HCT-om, liječenje je potrebno prekinuti do normalizacije natrijemije.
English: Exforge HCT is used to treat high blood pressure in adult patients whose blood pressure is already controlled while taking amlodipine, valsartan and hydrochlorothiazide and who may benefit from taking one tablet containing all three substances.
Croatian: Exforge HCT se primjenjuje za liječenje povišenog krvnog tlaka u odraslih bolesnika čiji je krvni tlak već kontroliran dok uzimaju amlodipin, valsartan i hidroklorotiazid te kojima uzimanje jedne tablete koja sadrži sve tri djelatne tvari može biti od koristi.
English: if you have or have had heart failure or coronary artery disease, particularly if you are prescribed the maximum dose of Exforge HCT (10 mg/320 mg/25 mg).
Croatian: ako imate ili ste imali zatajenje srca ili bolest koronarnih arterija, posebno ako je propisano da uzimate najvišu dozu Exforge HCT-a (10 mg/320 mg/25 mg).
English: If excessive hypotension occurs with Exforge HCT, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline.
Croatian: Ako se uz Exforge HCT pojavi izrazita hipotenzija, bolesnika treba poleći na leđa i po potrebi, mu dati intravensku infuziju fiziološke otopine.
English: When Exforge HCT is used in patients with renal impairment periodic monitoring of serum electrolytes (including potassium), creatinine and uric acid serum levels is recommended.
Croatian: Kada se Exforge HCT primjenjuje u bolesnika s oštećenjem bubrega preporučuje se periodičko praćenje serumskih elektrolita (uključujući kalij), razina kreatinina i mokraćne kiseline u serumu.
English: Other medicines and Exforge HCT
Croatian: Drugi lijekovi i Exforge HCT
English: In sodium-depleted and/or volume-depleted patients, such as those receiving high doses of diuretics, symptomatic hypotension may occur after initiation of treatment with Exforge HCT.
Croatian: U bolesnika sa sniženom razinom natrija i/ili smanjenjem volumena tekućine, poput onih koji primaju visoke doze diuretika, nakon početka liječenja Exforge HCT-om moguća je pojava simptomatske hipotenzije.
English: The safety profile of Exforge HCT presented below is based on clinical studies performed with Exforge HCT and the known safety profile of the individual components amlodipine, valsartan and hydrochlorothiazide.
Croatian: Niže prikazani sigurnosni profil Exforge HCT-a temelji se na kliničkim ispitivanjima Exforge HCT-a i poznatom sigurnosnom profilu pojedinačnih komponenti amlodipina, valsartana i hidroklorotiazida.
English: There is no experience on the use of Exforge HCT in pregnant women.
Croatian: Nema iskustva s primjenom Exforge HCT-a u trudnica.
English: The following adverse reactions, listed by MedDRA System Organ Class and frequency, concern Exforge HCT (amlodipine/valsartan/HCT) and amlodipine, valsartan and HCT individually.
Croatian: Sljedeće nuspojave, navedene prema MedDRA-inoj klasifikaciji organskih sustava i učestalosti, odnose se na Exforge HCT (amlodipin/valsartan/HCT) i amlodipin, valsartan i HCT pojedinačno.
English: In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Exforge HCT were minor and consistent with the pharmacological mechanism of action of the monotherapy agents.
Croatian: Promjene vrijednosti laboratorijskih parametera opažene s kombinacijom Exforge HCT tijekom 8tjednog kontroliranog kliničkog ispitivanja bile su manje i u skladu s farmakološkim mehanizmom djelovanja pojedinačnih komponenti.
English: Furthermore, concomitant use of Exforge HCT and NSAIDs may lead to worsening of renal function and an increase in serum potassium.
Croatian: Osim toga, istodobna primjena Exforge HCT-a i NSAIL-a može dovesti do pogoršanja bubrežne funkcije i povećanja kalija u serumu.
English: Exforge HCT tablets contain three substances called amlodipine, valsartan and hydrochlorothiazide.
Croatian: Exforge HCT tablete sadrže tri djelatne tvari koje se zovu amlodipin, valsartan i hidroklorotiazid.
English: The use of Exforge HCT during breastfeeding is not recommended.
Croatian: Primjena Exforge HCT-a tijekom dojenja se ne preporučuje.
English: When switching eligible elderly hypertensive patients (see section 4.1) to Exforge HCT, the lowest available dose of the amlodipine component should be used.
Croatian: Prilikom prebacivanja starijih hipertenzivnih bolesnika koji ispunjavaju uvjete za liječenje (vidjeti dio 4.1) na Exforge HCT, treba se koristiti najniža dostupna doza amlodipina kao komponente.
English: Due to the hydrochlorothiazide component, Exforge HCT is contraindicated for use in patients with anuria (see section 4.3) and in patients with severe renal impairment (glomerular filtration rate (GFR) <30 ml/min/1.73 m2) (see sections 4.3, 4.4 and 5.2).
Croatian: Zbog hidroklorotiazidne komponente, primjena Exforge HCT je kontraindicirana u bolesnika s anurijom (vidjeti dio 4.3) i u bolesnika s teškim oštećenjem bubrega (brzina glomerularne filtracije (GFR) <30 ml/min/1,73 m2) (vidjeti dijelove 4.3, 4.4 i 5.2).
English: The side effects reported with Exforge HCT or one of its three active substances (amlodipine, valsartan and hydrochlorothiazide) are listed below and may occur with the use of Exforge HCT.
Croatian: Nuspojave prijavljene za Exforge HCT ili za jednu od tri komponente (amlodipin, valsartan i hidroklorotiazid) navedene su niže i mogu se javiti kod uzimanja Exforge HCT.
English: The safety of Exforge HCT has been evaluated at its maximum dose of 10 mg/320 mg/25 mg in one controlled short-term (8 weeks) clinical study with 2,271 patients, 582 of whom received valsartan in combination with amlodipine and hydrochlorothiazide.
Croatian: Sigurnost primjene Exforge HCT-a je ispitivana u njegovoj najvišoj dozi od 10 mg/320 mg/25 mg u jednom kontroliranom kratkotrajnom (8 tjedana) kliničkom ispitivanju s 2271 bolesnikom, od kojih je 582 primalo valsartan u kombinaciji s amlodipinom i hidroklorotiazidom.
English: Exforge HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any pre-existing hypercalcaemia.
Croatian: Exforge HCT je kontraindiciran u bolesnika s hiperkalcijemijom te se smije primjenjivati tek nakon korekcije eventualne, već postojeće hiperkalcijemije.
English: If photosensitivity reaction occurs during treatment with Exforge HCT, it is recommended to stop the treatment.
Croatian: Ako se tijekom liječenja Exforge HCT-om javi fotosenzitivna reakcija, preporučuje se prekinuti liječenje.
English: Following oral administration of Exforge HCT in normal healthy adults, peak plasma concentrations of amlodipine, valsartan and hydrochlorothiazide are reached in 6-8 hours, 3 hours, and 2 hours, respectively.
Croatian: Nakon peroralne primjene Exforge HCT-a u normalnih, zdravih odraslih osoba, vršne koncentracije amlodipina u plazmi postižu se za 6-8 sati, valsartana unutar 3 sata, a hidroklorotiazida unutar 2 sata.
English: When switching eligible hypertensive patients (see section 4.1) with hepatic impairment to Exforge HCT, the lowest available dose of the amlodipine component should be used.
Croatian: Prilikom prebacivanja hipertenzivnih bolesnika koji ispunjavaju uvjete za liječenje (vidjeti dio 4.1) s oštećenjem jetre na Exforge HCT, treba se koristiti najniža dostupna doza amlodipina kao komponente.
English: No formal interaction studies with other medicinal products have been performed with Exforge HCT.
Croatian: Nisu provedena formalna ispitivanja interakcija Exforge HCT-a s drugim lijekovima.
English: Do not use any Exforge HCT pack that is damaged or shows signs of tampering.
Croatian: Exforge HCT se ne smije upotrijebiti ukoliko primjetite da je pakiranje oštećeno ili su vidljivi znakovi otvaranja.
English: If you stop taking Exforge HCT
Croatian: Ako prestanete uzimati Exforge HCT
English: In patients with mild to moderate hepatic impairment without cholestasis, the maximum recommended dose is 80 mg valsartan, and therefore, Exforge HCT is not suitable in this group of patients (see sections 4.2, 4.3 and 5.2).
Croatian: U bolesnika s blagim do umjerenim oštećenjem jetre, bez kolestaze, najviša preporučena doza valsartana je 80 mg, stoga Exforge HCT nije prikladan u toj skupini bolesnika (vidjeti dijelove 4.2, 4.3 i 5.2).
English: Caution is advised in patients with heart failure and coronary artery disease, particularly at the maximum dose of Exforge HCT, 10 mg/320 mg/25 mg, since available data in these patient populations is limited.
Croatian: Savjetuje se oprez u bolesnika sa zatajivanjem srca i bolešću koronarnih arterija, osobito pri najvišoj dozi Exforge HCT-a, 10 mg/320 mg/25 mg, jer su dostupni podaci u ovoj populaciji bolesnika ograničeni.
English: Concomitant use of Exforge HCT with aliskiren-containing products in patients with diabetes mellitus or renal impairment (GFR <60 ml/min/1.73 m2) (see sections 4.5 and 5.1).
Croatian: Istodobna primjena Exforge HCT s lijekovima koji sadrže aliskiren kontraindicirana je u bolesnika sa šećernom bolešću ili oštećenjem bubrega (GFR <60 ml/min/1,73 m2) (vidjeti dijelove 4.5 i 5.1).
English: This is because grapefruit and grapefruit juice can lead to an increase in the blood levels of the active substance amlodipine, which can cause an unpredictable increase in the blood pressure lowering effect of Exforge HCT.
Croatian: Grejp i sok od grejpa u nekih bolesnika može dovesti do povećanja razina djelatne tvari amlodipina u krvi, što može uzrokovati neočekivano pojačani učinak Exforge HCT-a na snižavanje krvnog tlaka.
English: At week 8, the mean reductions in systolic/diastolic blood pressure were 39.7/24.7 mmHg with Exforge HCT, 32.0/19.7 mmHg with valsartan/hydrochlorothiazide, 33.5/21.5 mmHg with amlodipine/valsartan, and 31.5/19.5 mmHg with amlodipine/hydrochlorothiazide.
Croatian: U 8. tjednu, srednja vrijednost sniženja sistoličkog/dijastoličkog krvnog tlaka bila je 39,7/24,7 mmHg s Exforge HCT-om, 32,0/19,7 mmHg s valsartanom/hidroklorotiazidom, 33,5/21,5 mmHg s amlodipinom/valsartanom te 31,5/19,5 mmHg s amlodipinom/hidroklorotiazidom.
English: If any of the above applies to you, do not take Exforge HCT and talk to your doctor.
Croatian: Ako se bilo što od navedenog odnosi na Vas, nemojte uzeti Exforge HCT i obavijestite svog liječnika.
English: The reductions in systolic/diastolic blood pressure with Exforge HCT were 7.6/5.0 mmHg greater than with valsartan/hydrochlorothiazide, 6.2/3.3 mmHg greater than with amlodipine/valsartan, and 8.2/5.3 mmHg greater than with amlodipine/hydrochlorothiazide.
Croatian: Sniženje sistoličkog/dijastoličkog krvnog tlaka postignuto Exforge HCT-om bilo je 7,6/5,0 mmHg veće nego s valsartanom/hidroklorotiazidom, za 6,2/3,3 mmHg veće od onog s amlodipinom/valsartanom te za 8,2/5,3 mmHg veće od onog s amlodipinom/hidroklorotiazidom.
English: The maximum recommended dose of Exforge HCT is 10 mg/320 mg/25 mg.
Croatian: Najviša preporučena doza Exforge HCT-a je 10 mg/320 mg/25 mg.
English: Exforge HCT should be used only after correction of any pre-existing sodium and/or volume depletion.
Croatian: Exforge HCT smije se primjenjivati tek nakon korigiranja snižene razine natrija i/ili volumena tekućine.
English: If you forget to take Exforge HCT
Croatian: Ako ste zaboravili uzeti Exforge HCT
English: Exforge HCT is contraindicated in patients with severe renal impairment, anuria or undergoing dialysis (see section 4.3).
Croatian: Exforge HCT je kontraindiciran u bolesnika s teškim oštećenjem bubrega, anurijom ili u bolesnika na dijalizi (vidjeti dio 4.3).
English: Due to the valsartan component, Exforge HCT is contraindicated in patients with severe hepatic impairment (see section 4.3).
Croatian: Zbog komponente valsartana, Exforge HCT je kontraindiciran u bolesnika s teškim oštećenjem jetre (vidjeti dio 4.3).
English: In patients with mild to moderate hepatic impairment without cholestasis, the maximum recommended dose is 80 mg valsartan and therefore Exforge HCT is not suitable in this group of patients (see sections 4.3, 4.4 and 5.2).
Croatian: U bolesnika s blagim do umjerenim oštećenjem jetre, bez kolestaze, najviša preporučena doza valsartana je 80 mg te Exforge HCT stoga nije pogodan za ovu skupinu bolesnika (vidjeti dijelove 4.3, 4.4 i 5.2).
English: an ACE inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
Croatian: ako uzimate bilo koji od lijekova navedenih u nastavku, koji se koriste za liječenje visokog krvnog tlaka: ACE inhibitor (primjerice enalapril, lisinopril, ramipril), osobito ako imate bubrežne tegobe povezane sa šećernom bolešću. aliskiren.
English: Due to the valsartan component, Exforge HCT is contraindicated in patients with hepatic impairment (see sections 4.2 and 4.3).
Croatian: Zbog valsartanske komponente Exforge HCT je kontraindiciran u bolesnika s oštećenjem jetre (vidjeti djelove 4.2 i 4.3).
English: There are no clinical studies on fertility with Exforge HCT.
Croatian: Ne postoje klinička ispitivanja djelovanja Exforge HCT-a na plodnost.
English: Caution is advised in patients with heart failure and coronary artery disease, particularly at the maximum dose of Exforge HCT, 10 mg/320 mg/25 mg.
Croatian: Savjetuje se oprez u bolesnika sa zatajenjem srca i bolešću koronarnih arterija, posebno u najvišoj dozi Exforge HCT-a, 10 mg/320 mg/25 mg.
English: Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets Exforge HCT 5 mg/160 mg/25 mg film-coated tablets Exforge HCT 10 mg/160 mg/25 mg film-coated tablets Exforge HCT 10 mg/320 mg/25 mg film-coated tablets
Croatian: Exforge HCT 5 mg/160 mg/12,5 mg filmom obložene tablete Exforge HCT 10 mg/160 mg/12,5 mg filmom obložene tablete Exforge HCT 5 mg/160 mg/25 mg filmom obložene tablete Exforge HCT 10 mg/160 mg/25 mg filmom obložene tablete Exforge HCT 10 mg/320 mg/25 mg filmom obložene tablete
English: How to take Exforge HCT
Croatian: Kako uzimati Exforge HCT
English: Exforge HCT should be discontinued immediately in patients who develop angioedema and should not be re-administered.
Croatian: Bolesnici u kojih se razvije angioedem trebaju odmah prekinuti primjenu Exforge HCT-a i više ga ne smiju ponovo uzimati.
English: This is a disease in which the adrenal glands make too much of the hormone aldosterone If this applies to you, the use of Exforge HCT is not recommended.
Croatian: To je bolest kod koje nadbubrežne žlijezde stvaraju previše hormona aldosterona.
English: Excessive hypotension, including orthostatic hypotension, was seen in 1.7% of patients treated with the maximum dose of Exforge HCT (10 mg/320 mg/25 mg) compared to 1.8% of valsartan/hydrochlorothiazide (320 mg/25 mg) patients, 0.4% of amlodipine/valsartan (10 mg/320 mg) patients, and 0.2% of hydrochlorothiazide/amlodipine (25 mg/10 mg) patients in a controlled trial in patients with moderate to severe uncomplicated hypertension.
Croatian: U kontroliranom ispitivanju provedenom u bolesnika s umjerenom do teškom nekompliciranom hipertenzijom, izrazita hipotenzija, uključujući ortostatsku hipotenziju, viđena je u 1,7% bolesnika liječenih najvišom dozom Exforge HCT-a (10 mg/320 mg/25 mg) u usporedbi s 1,8% bolesnika liječenih valsartanom/hidroklorotiazidom (320 mg/25 mg), 0,4% bolesnika liječenih amlodipinom/valsartanom (10 mg/320 mg) i 0,2% bolesnika liječenih hidroklorotiazidom/amlodipinom (25 mg/10 mg).
English: Treatment with Exforge HCT should only start after correction of hypokalaemia and any coexisting hypomagnesaemia.
Croatian: Liječenje Exforge HCT-om smije se započeti tek nakon korigiranja hipokalijemije i eventualne prateće hipomagnezijemije.
English: If you take more Exforge HCT than you should If you have accidentally taken too many Exforge HCT tablets, talk to a doctor immediately.You may require medical attention.
Croatian: Ako ste slučajno uzeli previše tableta Exforge HCT-a, odmah se obratite liječniku.
English: Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets Exforge HCT 5 mg/160 mg/25 mg film-coated tablets Exforge HCT 10 mg/160 mg/25 mg film-coated tablets Exforge HCT 10 mg/320 mg/25 mg film-coated tablets amlodipine/valsartan/hydrochlorothiazide
Croatian: Exforge HCT 5 mg/160 mg/12,5 mg filmom obložene tablete Exforge HCT 10 mg/160 mg/12,5 mg filmom obložene tablete Exforge HCT 5 mg/160 mg/25 mg filmom obložene tablete Exforge HCT 10 mg/160 mg/25 mg filmom obložene tablete Exforge HCT 10 mg/320 mg/25 mg filmom obložene tablete amlodipin/valsartan/hidroklorotiazid
English: Grapefruit and grapefruit juice should not be consumed by people who are prescribed Exforge HCT.
Croatian: Bolesnici kojima je propisan Exforge HCT ne smiju konzumirati grejp ili sok od grejpa.
English: There is no experience of overdose with Exforge HCT.
Croatian: Nema iskustva s predoziranjem Exforge HCT-om.
English: Exforge HCT individual component
Croatian: Pojedinačna komponenta Exforge HCT-a
English: Exforge HCT 10 mg/320 mg/25 mg film-coated tablets
Croatian: Exforge HCT 10 mg/320 mg/25 mg filmom obložene tablete
English: What Exforge HCT looks like and contents of the pack Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets are white, oval tablets with “NVR” on one side and “VCL” on the other side.
Croatian: Kako Exforge HCT izgleda i sadržaj pakiranja Exforge HCT 5 mg/160 mg/12,5 mg filmom obložene tablete su bijele, ovalne tablete s oznakom „NVR“ na jednoj strani i „VCL“ na drugoj strani.
English: Frequency Exforge HCT
Croatian: Učestalost Exforge HCT
English: How to store Exforge HCT
Croatian: Kako čuvati Exforge HCT
English: if you experience dizziness and/or fainting during treatment with Exforge HCT, tell your doctor as soon as possible.
Croatian: Nemojte više nikad uzimati Exforge HCT. ako tijekom liječenja Exforge HCT-om osjetite omaglicu i/ili nesvjesticu, o tome što prije obavijestite svoga liječnika.
English: Exforge HCT should be discontinued if hypercalcaemia develops during treatment.
Croatian: Ako se tijekom liječenja Exforge HCT-om razvije hiperkalcijemija, liječenje treba prekinuti.
English: Blood potassium decreased Uncommon Blood potassium increased
Croatian: Povišena dušična urea u krvi Manje često -Povišena mokraćna kiselina u krvi
English: EU/1/09/569/007 280 film-coated tablets
Croatian: EU/1/09/569/007 280 filmom obloženih tableta
English: There is limited experience with the use of Exforge HCT, particulary at the maximum dose, in patients with heart failure and coronary artery disease.
Croatian: U bolesnika sa zatajenjem srca i bolešću koronarnih arterija postoji ograničeno iskustvo s primjenom Exforge HCT-a, posebno u najvišoj dozi.
English: EU/1/09/569/016 56 film-coated tablets
Croatian: EU/1/09/569/016 56 filmom obloženih tableta
English: EU/1/09/569/042 98 film-coated tablets
Croatian: EU/1/09/569/042 98 filmom obloženih tableta
English: EU/1/09/569/043 280 film-coated tablets
Croatian: EU/1/09/569/043 280 filmom obloženih tableta
English: EU/1/09/569/004 56 film-coated tablets
Croatian: EU/1/09/569/004 56 filmom obloženih tableta
English: EU/1/09/569/018 98 film-coated tablets
Croatian: EU/1/09/569/018 98 filmom obloženih tableta
English: Exforge HCT 10 mg/160 mg/25 mg film-coated tablets
Croatian: Exforge HCT 10 mg/160 mg/25 mg filmom obložene tablete
English: EU/1/09/569/027 30 film-coated tablets
Croatian: EU/1/09/569/027 30 filmom obloženih tableta
English: Exforge HCT 5 mg/160 mg/25 mg film-coated tablets
Croatian: Exforge HCT 5 mg/160 mg/25 mg filmom obložene tablete
English: Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets
Croatian: Exforge HCT 10 mg/160 mg/12,5 mg filmom obložene tablete
English: Exforge HCT 5 mg/160 mg/12.5 mg film-coated tablets
Croatian: Exforge HCT 5 mg/160 mg/12,5 mg filmom obložene tablete
English: EU/1/09/569/041 90 film-coated tablets
Croatian: EU/1/09/569/041 90 filmom obloženih tableta
English: EU/1/09/569/038 28 film-coated tablets
Croatian: EU/1/09/569/038 28 filmom obloženih tableta
English: Exforge HCT 10 mg/320 mg/25 mg film-coated tablets are brown-yellow, oval tablets with “NVR” on one side and “VFL” on the other side.
Croatian: Exforge HCT 10 mg/320 mg/25 mg filmom obložene tablete su žuto-smeđe, ovalne tablete s oznakom „NVR“ na jednoj strani i „VFL“ na drugoj strani.
English: EU/1/09/569/031 280 film-coated tablets
Croatian: EU/1/09/569/031 280 filmom obloženih tableta
English: Exforge HCT 10 mg/160 mg/12.5 mg film-coated tablets are pale yellow, oval tablets with “NVR” on one side and “VDL” on the other side.
Croatian: Exforge HCT 10 mg/160 mg/12,5 mg filmom obložene tablete su blijedo žute, ovalne tablete s oznakom „NVR“ na jednoj strani i „VDL“ na drugoj strani.
English: EU/1/09/569/054 98 film-coated tablets
Croatian: EU/1/09/569/054 98 filmom obloženih tableta
English: EU/1/09/569/006 98 film-coated tablets
Croatian: EU/1/09/569/006 98 filmom obloženih tableta
English: EU/1/09/569/026 28 film-coated tablets
Croatian: EU/1/09/569/026 28 filmom obloženih tableta
English: EU/1/09/569/055 280 film-coated tablets
Croatian: EU/1/09/569/055 280 filmom obloženih tableta
English: EU/1/09/569/040 56 film-coated tablets
Croatian: EU/1/09/569/040 56 filmom obloženih tableta